Sudden onset of nephrotic syndrome in an asymptomatic Fabry patient: a case report

References

• Yalın SF, Eren N, Sinangil A, et al. Fabry disease prevalence in renal replacement therapy in Turkey. Nephron. 2019;142(1):26–33.
   PubMed Web of Science ®Google Scholar
• Sessa A, Meroni M, Battini G, et al. Chronic renal failure, dialysis, and renal transplantation in Anderson-Fabry disease. Semin Nephrol. 2004;24(5):532–536.
   PubMed Web of Science ®Google Scholar
• Germain DP. Fabry disease. Orphanet J Rare Dis. 2010;5(1):30.
   PubMedGoogle Scholar
• Zarate YA, Hopkin RJ. Fabry’s disease. Lancet. 2008;372(9647):1427–1435.
   PubMed Web of Science ®Google Scholar
• Mechtler TP, Stary S, Metz TF, et al. Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria. Lancet. 2012;379(9813):335–341.
   PubMed Web of Science ®Google Scholar
• Spada M, Pagliardini S, Yasuda M, et al. High incidence of later-onset Fabry disease revealed by newborn screening. Am J Hum Genet. 2006;79(1):31–40.
   PubMed Web of Science ®Google Scholar
• Mehta A, Ricci R, Widmer U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey. Eur J Clin Invest. 2004;34(3):236–242.
   PubMed Web of Science ®Google Scholar
• Arends M, Wanner C, Hughes D, et al. Characterization of classical and nonclassical Fabry disease: a multicenter study. JASN. 2017;28(5):1631–1641.
   Web of Science ®Google Scholar
• Whybra C, Kampmann C, Willers I, et al. Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherit Metab Dis. 2001;24(7):715–724.
   PubMed Web of Science ®Google Scholar
• Pinto LLC, Vieira TA, Giugliani R, et al. Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review. Orphanet J Rare Dis. 2010;5:14–14.
   PubMed Web of Science ®Google Scholar
• Hsu T-R, Chang F-P, Chu T-H, et al. Correlations between endomyocardial biopsies and cardiac manifestations in Taiwanese patients with the Chinese hotspot IVS4 + 919G > A mutation: data from the Fabry outcome survey. IJMS. 2017;18(1):119.
   Google Scholar
• Fabry J. Ein Beitrag zur Kenntniss der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae. Arch f Dermat. 1898;43(1):187–200.
   Google Scholar
• Garzuly F, Maródi L, Erdös M, et al. Megadolichobasilar anomaly with thrombosis in a family with Fabry’s disease and a novel mutation in the alpha-galactosidase A gene. Brain. 2005;128(Pt 9):2078–2083.
   PubMedGoogle Scholar
• Tuttolomondo A, Pecoraro R, Simonetta I, et al. Anderson-Fabry disease: a multiorgan disease. Curr Pharm Des. 2013;19(33):5974–5996.
   PubMed Web of Science ®Google Scholar
• Ishii S, Chang H-H, Kawasaki K, et al. Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin. Biochem J. 2007;406(2):285–295.
   PubMedGoogle Scholar
• Oliveira JP, Ferreira S. Multiple phenotypic domains of Fabry disease and their relevance for establishing genotype-phenotype correlations. Appl Clin Genet. 2019;12:35–50.
   PubMed Web of Science ®Google Scholar
• Branton MH, Schiffmann R, Sabnis SG, et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore). 2002;81(2):122–138.
   PubMed Web of Science ®Google Scholar
• Linthorst GE, Bouwman MG, Wijburg FA, et al. Screening for Fabry disease in high-risk populations: a systematic review. J Med Genet. 2010;47(4):217–222.
   PubMed Web of Science ®Google Scholar
• Yeniçerioğlu Y, Akdam H, Dursun B, et al. Screening Fabry’s disease in chronic kidney disease patients not on dialysis: a multicenter study. Ren Fail. 2017;39(1):104–111.
   PubMed Web of Science ®Google Scholar
• Fujisawa H, Nakayama Y, Nakao S, et al. Effectiveness of immunosuppressive therapy for nephrotic syndrome in a patient with late-onset Fabry disease: a case report and literature review. BMC Nephrol. 2019;20(1):469–469.
   PubMed Web of Science ®Google Scholar
• Reyes Marín FA, Gómez Navarro B, Tamayo y Orozco J, et al. Nephropathy in a case of Fabry’s disease. Revista de investigacion clinica. Organo Del Hospital de Enfermedades de la Nutricion. 1991;43(4):373–376.
   Google Scholar
• Majima K, Ishizaki T, Inoue T, et al. A case of Fabry’s disease associated with lupus nephritis. Nihon Jinzo Gakkai Shi. 1992;34(11):1189–1194.
   PubMedGoogle Scholar
• Thamboo TP, Sivaraman P, Chan NH-L. Pathologic quiz case: an unsuspected cause of nephrotic syndrome. Heterozygous Fabry disease. Arch Pathol Lab Med. 2004;128(5):593–594.
   PubMed Web of Science ®Google Scholar
• Inagaki S-i, Migita M, Hayakawa M, et al. An asymptomatic heterozygous female with Fabry disease: implications for enzyme replacement therapy. J Nippon Med Sch. 2005;72(6):387–390.
   PubMedGoogle Scholar
• Fischer EG, Moore MJ, Lager DJ. Fabry disease: a morphologic study of 11 cases. Mod Pathol. 2006;19(10):1295–1301.
   PubMed Web of Science ®Google Scholar
• Zarate YA, Patterson L, Yin H, et al. A case of minimal change disease in a Fabry patient. Pediatr Nephrol. 2010;25(3):553–556.
   PubMed Web of Science ®Google Scholar
• Zhou W, Ni Z, Zhang M. Hemizygous Fabry disease associated with membranous nephropathy: a rare case report. Clin Nephrol. 2018;90(3):227–231.
   PubMed Web of Science ®Google Scholar
• Shankland SJ. The podocyte’s response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006;69(12):2131–2147.
   PubMed Web of Science ®Google Scholar
• Germain DP, Shabbeer J, Cotigny S, et al. Fabry disease: twenty novel α-galactosidase A mutations and genotype-phenotype correlations in classical and variant phenotypes. Mol Med. 2002;8(6):306–312.
   PubMed Web of Science ®Google Scholar
• Topaloglu AK, Ashley GA, Tong B, et al. Twenty novel mutations in the α-galactosidase A gene causing Fabry disease. Mol Med. 1999;5(12):806–811.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang Y, Zhu F, et al. A missense mutation of the α-galactosidase A gene in a Chinese family of Fabry Disease with renal failure. Kidney Blood Press Res. 2013;37(4–5):221–228.
   PubMed Web of Science ®Google Scholar